You are using an older browser version. Please use a supported version for the best MSN experience.

Papa John’s Auditor Swap Is Not A Good Look

In today’s MarketFoolery, host Chris Hill and Motley Fool analyst Ron Gross look at big retail mix-ups, pharma mergers, and shady restaurant news. Pfizer (NYSE: PFE) dropped $11.5 billion to tuck Array BioPharma (NASDAQ: ARRY) and its cancer drugs under its belt. Target (NYSE: TGT) had multiple tech snafus in a row this weekend, but the company assures customers and investors that it wasn’t hack-related. Papa John’s (NASDAQ: PZZA) parts ways with their old auditor, an auditor that had some sharp words about the Papa style of financial reporting. Also, the hosts answer a listener question: is it OK to sell a dud that you know will be a dud for years, then put that money into something more promising? Tune in to find out more. ------------------------------------------------------------------------ Subscribe to The Motley Fool's YouTube Channel: Join our Facebook community: Follow The Motley Fool on Twitter:



Formula 1



Featured Partners

image beaconimage beaconimage beacon